Savara Inc.
SVRA

$556.05 M
Marketcap
$3.24
Share price
Country
$0.07
Change (1 day)
$5.70
Year High
$2.82
Year Low
Categories

Savara Inc., a clinical stage biopharmaceutical company, focuses on rare respiratory diseases. Its lead product candidate is molgramostim, an inhaled granulocyte-macrophage colony-stimulating factor, which is in Phase III development stage for the treatment of autoimmune pulmonary alveolar proteinosis. The company is headquartered in Austin, Texas.

marketcap

Stock price history for Savara Inc. (SVRA)

Highest end of day price: $9240.00 USD on 2006-04-20

Lowest end of day price: $0.71 USD on 2019-11-14

Stock price history of Savara Inc. from 2004 to 2024